Detalhe da pesquisa
1.
Identification of bacteria-derived HLA-bound peptides in melanoma.
Nature
; 592(7852): 138-143, 2021 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-33731925
2.
TP53 missense mutations in PDAC are associated with enhanced fibrosis and an immunosuppressive microenvironment.
Proc Natl Acad Sci U S A
; 118(23)2021 06 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34088837
3.
Dermatological adverse events under programmed cell death-1 inhibitors as a prognostic marker in metastatic melanoma.
Dermatol Ther
; 35(10): e15747, 2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36190005
4.
Long-term real-world experience with ipilimumab and non-ipilimumab therapies in advanced melanoma: the IMAGE study.
BMC Cancer
; 21(1): 642, 2021 May 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051732
5.
[THE IMPACT OF ARTIFICIAL INTELLIGENCE AND BIG DATA ON HEALTHCARE].
Harefuah
; 160(1): 24-29, 2021 Jan.
Artigo
em Hebraico
| MEDLINE | ID: mdl-33474875
6.
Potent Activation of Human T Cells by mRNA Encoding Constitutively Active CD40.
J Immunol
; 201(10): 2959-2968, 2018 11 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-30305327
7.
Pembrolizumab versus ipilimumab in advanced melanoma (KEYNOTE-006): post-hoc 5-year results from an open-label, multicentre, randomised, controlled, phase 3 study.
Lancet Oncol
; 20(9): 1239-1251, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31345627
8.
Predicting response to pembrolizumab in metastatic melanoma by a new personalization algorithm.
J Transl Med
; 17(1): 338, 2019 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-31590677
9.
BASELINE TSH LEVEL IS ASSOCIATED WITH RISK OF ANTI-PD-1-INDUCED THYROID DYSFUNCTION.
Endocr Pract
; 25(8): 824-829, 2019 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-31013164
10.
Pembrolizumab versus ipilimumab for advanced melanoma: final overall survival results of a multicentre, randomised, open-label phase 3 study (KEYNOTE-006).
Lancet
; 390(10105): 1853-1862, 2017 Oct 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-28822576
11.
Pembrolizumab versus Ipilimumab in Advanced Melanoma.
N Engl J Med
; 372(26): 2521-32, 2015 Jun 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-25891173
12.
Neurologic complications of immune checkpoint inhibitors.
J Neurooncol
; 137(3): 601-609, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29332184
13.
Exploring the potential of mucin 13 (MUC13) as a biomarker for carcinomas and other diseases.
Clin Chem Lab Med
; 56(11): 1945-1953, 2018 10 25.
Artigo
em Inglês
| MEDLINE | ID: mdl-29768245
14.
[THE PARADIGM SHIFT IN MEDICINE FOLLOWING THE 4TH INDUSTRIAL REVOLUTION].
Harefuah
; 157(12): 797-801, 2018 Dec.
Artigo
em Hebraico
| MEDLINE | ID: mdl-30582315
15.
Giant congenital melanocytic naevus with a novel CUX1-BRAF fusion mutation treated with trametinib.
Br J Dermatol
; 187(6): 1052-1054, 2022 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-36030465
16.
COVID-19 vaccine as a cause for unilateral lymphadenopathy detected by 18F-FDG PET/CT in a patient affected by melanoma.
Eur J Nucl Med Mol Imaging
; 48(8): 2659-2660, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-33675368
17.
Imprinting of lymphocytes with melanoma antigens acquired by trogocytosis facilitates identification of tumor-reactive T cells.
J Immunol
; 190(11): 5856-65, 2013 Jun 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-23626012
18.
Ipilimumab plus dacarbazine for previously untreated metastatic melanoma.
N Engl J Med
; 364(26): 2517-26, 2011 Jun 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-21639810
19.
Tumor mutational burden and response to programmed cell death protein 1 inhibitors in a case series of patients with metastatic desmoplastic melanoma.
J Am Acad Dermatol
; 80(6): 1780-1782, 2019 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-30576761
20.
Trogocytosis is a gateway to characterize functional diversity in melanoma-specific CD8+ T cell clones.
J Immunol
; 188(2): 632-40, 2012 Jan 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22156347